Contributed Indexology®: Effects Of Pharmaceutical Regulation By S&P Dow Jones IndicesOctober 21, 2015
Contributed Will A Profit Recession Weigh On ETFs? By Russ Koesterich -- BlackRock Chief Investment StrategistOctober 21, 2015
Contributed What To Make Of 0% Yield By Matt Tucker -- iShares Head of Fixed Income StrategyOctober 19, 2015
Contributed An Overlooked, Troubling Indicator By Russ Koesterich -- BlackRock Chief Investment StrategistOctober 18, 2015
Contributed ETF Inflows Surge Despite Market Uncertainty By David Mazza -- State Street Global AdvisorsOctober 17, 2015
Contributed 3 Recession Signposts To Watch By Russ Koesterich -- BlackRock Chief Investment StrategistOctober 17, 2015
Contributed Indexology®: SPIVA Interpretation and Misinterpretation By S&P Dow Jones IndicesOctober 15, 2015